Angiostatic Proteins
- Name
- Angiostatic Proteins
- Accession Number
- DBCAT001797
- Description
Proteins that specifically inhibit the growth of new blood vessels (ANGIOGENESIS, PHYSIOLOGIC).
- Drugs
Drug Drug Description Endostatin Investigated for use/treatment in cancer/tumors (unspecified), macular degeneration, and diabetic retinopathy. Endostar Endostar is under investigation for the treatment of Nasopharyngeal Carcinoma. Endostar has been investigated for the treatment of Non-small Cell Lung Cancer. - Drugs & Drug Targets
Drug Target Type Endostatin 72 kDa type IV collagenase target Endostatin Matrix metalloproteinase-9 target Endostatin Collagenase 3 target Endostatin Focal adhesion kinase 1 target Endostatin E-selectin target Endostatin Cytochrome P450 19A1 enzyme